BACKGROUND: Alterations in the tumor suppressor gene p53 are the most frequently detected genetic abnormalities in human cancers. Inactivated tumor suppressor genes, including p53, often are suggested by loss of heterozygosity (LOH) studies. p53 gene inactivation has been reported in esophageal cancers. Because the etiologic factors for esophageal and intraoral carcinomas often are the same, corresponding molecular events may occur in oral squamous cell carcinoma (SCC) development. METHODS: The authors investigated LOH of the p53 gene in DNA from 27 primary oral cancers using a polymerase chain reaction (PCR)-based restriction fragment length polymorphism assay. DNA from fixed specimens of SCC and normal tissues was isolated and amplified at two p53 gene polymorphic restriction sites. RESULTS: In heterozygous individuals, 10 of 14 (71%) intraoral SCC demonstrated loss of p53 heterozygosity at one polymorphic restriction site. Two of five carcinomas showed LOH at a second site. CONCLUSIONS: These results suggest that inactivation of p53 is involved in the development or progression of SCC of the oral cavity.
BACKGROUND: Alterations in the tumor suppressor gene p53 are the most frequently detected genetic abnormalities in humancancers. Inactivated tumor suppressor genes, including p53, often are suggested by loss of heterozygosity (LOH) studies. p53 gene inactivation has been reported in esophageal cancers. Because the etiologic factors for esophageal and intraoral carcinomas often are the same, corresponding molecular events may occur in oral squamous cell carcinoma (SCC) development. METHODS: The authors investigated LOH of the p53 gene in DNA from 27 primary oral cancers using a polymerase chain reaction (PCR)-based restriction fragment length polymorphism assay. DNA from fixed specimens of SCC and normal tissues was isolated and amplified at two p53 gene polymorphic restriction sites. RESULTS: In heterozygous individuals, 10 of 14 (71%) intraoral SCC demonstrated loss of p53 heterozygosity at one polymorphic restriction site. Two of five carcinomas showed LOH at a second site. CONCLUSIONS: These results suggest that inactivation of p53 is involved in the development or progression of SCC of the oral cavity.
Authors: Joon-Yong Chung; Joo Mi Yi; Ran Xie; Victoria Brown; Olivia Lee; Nita Ahuja; Till Braunschweig; Stephen M Hewitt Journal: Anal Biochem Date: 2012-03-23 Impact factor: 3.365
Authors: Y Q Li; Z P Pavelic; L J Wang; J S McDonald; L Gleich; E Munck-Wikland; S Dacic; Z Danilovic; L J Pavelic; K M Wilson; J L Gluckman; P J Stambrook Journal: Clin Mol Pathol Date: 1995-10